Ambulant treatment according to protocol of deep venous thrombosis in a leg: Efficacious and safe in everyday practice;Protocollaire thuisbehandeling van diepe veneuze trombose in een been: Effectief en veilig in de dagelijkse praktijk

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 12, 2000, Pages 557-560

  Van Hulsteijn, L H ^a,b   Brenninkmeijer, B J ^a,b   Trugg R A ^a   Litjens Van De Ven, A J A ^a,c   Huisman, M V ^a  

^a BERNHOVEN HOSPITAL   (Netherlands)

^b Werkgroep D   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEEP VEIN THROMBOSIS; EMERGENCY WARD; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS; THROMBOPHLEBITIS;

EID: 0034681777     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Brandjes DPM, Heijboer H, Büller HR, Rijk M de, Jagt H, Cate JW ten. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992;327:1485-9.
2. Lensing AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A metaanalysis. Arch Intern Med 1995;155:601-7.
3. Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, Meer J van der, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996;334: 682-7.
4. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
5. Belt AG van den, Bossuyt PM, Prins MH, Gallus AS, Büller HR. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis - an economic evaluation. TASMAN Study Group. Thromb Haemost 1998;79:259-63.
6. Lensing AWA, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella S, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320:342-5.
7. Heijboer H, Büller HR, Lensing AW, Turpie AG, Colly LP, Cate JW ten. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med 1993;329: 1365-9.
8. Wells PS. Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, et al. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient sell-injection with homecare injection. Arch Intern Med 1998:158:1809-12.